Antibe Therapeutics Inc is leveraging its proprietary hydrogen sulfide platform to develop next-generation safer therapies to target inflammation arising from a wide range of medical conditions... Show more
Industry Biotechnology
A.I.dvisor indicates that over the last year, ATBPF has been loosely correlated with IRON. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if ATBPF jumps, then IRON could also see price increases.
| Ticker / NAME | Correlation To ATBPF | 1D Price Change % | ||
|---|---|---|---|---|
| ATBPF | 100% | N/A | ||
| IRON - ATBPF | 53% Loosely correlated | +5.36% | ||
| KMSTF - ATBPF | 52% Loosely correlated | N/A | ||
| SRZN - ATBPF | 47% Loosely correlated | -4.19% | ||
| CDIO - ATBPF | 25% Poorly correlated | -15.02% | ||
| ZVRA - ATBPF | 22% Poorly correlated | -1.52% | ||
More | ||||